This year is already off to a busy start, and Dermatology Times is prepared to provide our readers with the most up-to-date clinical content from innovative studies and FDA approvals to exclusive interviews and expert insights.
Improving access to care for all patients is the goal of every clinician, no matter the specialty. In dermatology, FDA approvals of new therapeutic agents for multiple conditions seem to occur nonstop, constantly improving the lives of patients across the country. But what about rare diseases? This year, February 29 is Rare Disease Day, and Dermatology Times’ cover feature focuses on the use of artificial intelligence in dermatology to help collect cohort data of rare diseases to improve digital phenotyping and decrease the delay in diagnosis of rare dermatologic conditions. OM1’s Joseph Zabinski, PhD, MEM, and Stefan Weiss, MD, MBA, FAAD, dive into OM1’s Patient Finder technology that aids in the patterning and signaling information found in patients’ data histories.
This month’s issue also features exclusive insights from Becky Kamowitz, senior director of marketing communications at the Skin Cancer Foundation, and Jesse Lewin, MD, FACMS, chief of Mohs micrographic surgery at Mount Sinai in New York, about the Skin Cancer Foundation’s traveling Destination Healthy Skin program to promote early skin cancer detection.
As 2024 begins to gain momentum, Dermatology Times is looking forward to the most anticipated meeting of the year, the 2024 American Academy of Dermatology (AAD) Annual Meeting, which will be held March 8 to 12, 2024, in San Diego, California. Dermatology Times will be attending in person to bring our readers the newest late-breaking research, treatment pearls, and exclusive key opinion leader interviews. If you are presenting at AAD, we would love to hear from you; email DTEditor@mmhgroup.com for an opportunity to discuss your research.
For an in-depth look at patient progress photos for improving skin smoothness and vitiligo repigmenation on the lips, be sure to check out pages 16 and 18. Malka Niknamfard, PA-C, dives into a case report of one patient’s vitiligo journey. Paul Friedman, MD, provides key insights into UltraClear Laser-Coring benefits and device tips for clinicians.
This year is already off to a busy start, and Dermatology Times is prepared to provide our readers with the most up-to-date clinical content from innovative studies and FDA approvals to exclusive interviews and expert insights. Keep up with the latest data and subscribe to Dermatology Times e-newsletters, follow us on social media, and email us with ideas and feedback at DTEditor@mmhgroup.com.